Antidepressive Agents, Tricyclic - Adverse effects
Research News and Information

Monday, November 23, 2009

[Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices]

3 Oct 2009 INTRODUCTION: The consumption of benzodiazepines (BZ) and cyclopyrrolones (CP) has attracted great interest in recent years due to the serious side-effects associated with these drugs. Two medical practices introduced a more restrictive approach to ... Read more...

Treatment-resistant depression.

13 Jul 2009 Up to two thirds of patients with major unipolar depression will not respond to the first medication prescribed. Depression may be considered resistant to treatment when at least two trials with antidepressants from different pharmacologic classes ... Read more...

New onset somnambulism associated with different dosage of mirtazapine: a case report.

29 Jun 2009 Somnambulism consists of variously complex behaviors that may result in harm to self or to others. Many different medications have been reported to induce somnambulism, and a few of them are newer antidepressants. A 40-year-old woman with history of ... Read more...

Latest indexed articles for 'Antidepressive Agents, Tricyclic - Adverse effects'

These are the very latest articles for this heading:

• [Benzodiazepine reduction does not imply an increased consumption of antidepressants. A survey of two medical practices] 3 Oct 2009
• Selective serotonin reuptake inhibitor-induced spermatorrhea in 2 patients. 30 Jul 2009
• Treatment-resistant depression. 13 Jul 2009
• New onset somnambulism associated with different dosage of mirtazapine: a case report. 29 Jun 2009
• [From case to case: depression and delusions] 29 Jun 2009
• Imipramine-induced hyperpigmentation: a case report and review of the literature. 29 Jun 2009
• Efficacy, tolerability and safety of tianeptine in special populations of depressive patients. 30 May 2009
• [Psychopharmacological treatments in childhood and adolescence] 30 May 2009
• Depression and cognitive complaints following mild traumatic brain injury. 30 May 2009
• Mirtazapine-associated hyponatremia in an elderly patient. 10 May 2009
• A case of imipramine-associated immune thrombocytopenia. 29 Apr 2009
• Repeated episodes of neutropenia triggered by mirtazapine. 29 Apr 2009
• Antidepressants, thiazide diuretics and alcoholism: central pontine myelinolysis waiting to happen? 29 Apr 2009
• Is there sufficient evidence to suggest cyclobenzaprine might be implicated in causing serotonin toxicity? 29 Apr 2009
• Pharmacokinetics and efficacy of fluvoxamine and amitriptyline in depression. 29 Apr 2009
• High mirtazapine plasma levels in infant after breast feeding: case report and review of the literature. 30 Mar 2009
• Irritable bowel syndrome: a mild disorder; purely symptomatic treatment. 30 Mar 2009
• Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. 30 Mar 2009
• Megestrol acetate and mirtazapine for the treatment of unplanned weight loss in the elderly. 30 Mar 2009
• Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant. 28 Mar 2009

See a longer list of these articles.

Technical information about 'Antidepressive Agents, Tricyclic'

Definition: Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system.

Registry Number: 0

Descriptor UI: D000929

Alternative terms: Antidepressive Agents, Tricyclic; Antidepressant Drugs, Tricyclic; Drugs, Tricyclic Antidepressant; Tricyclic Antidepressant Drugs; Antidepressants, Tricyclic; Tricyclic Antidepressants; Tricyclic Antidepressive Agents; Agents, Tricyclic Antidepressive;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.427.700.122.055;

History Note: 75

Technical Notes: GEN or unspecified; prefer specifics